Hesham Sabry is the new General Manager of Roche Bulgaria. He takes over the management of the company’s affiliate in our country from 1st April this year.
Hesham Sabry has extensive experience in healthcare. Since January 2003, he has held successive positions and functions in four multinational pharmaceutical companies – Eli Lilly, Johnson & Johnson, Novartis Oncology and Roche.
Mr. Sabry joined Roche in January 2015 as Director of the Oncology Business Division of the company’s representative office in Saudi Arabia. In February 2017, he participated in a global rotation programme, where he worked with Roche’s international business team focusing on cancer immunotherapy. Eight months later, he became the General Manager of Roche’s representative office in Jordan and Palestine, and in January 2019 he became the head and General Manager of Roche Pharmaceuticals Levant (Lebanon, Jordan, Syria and Palestine).
Hesham Sabry graduated in Pharmaceutical Sciences from the University of Cairo, Egypt. He later earned a master’s degree in business administration with a specialization in marketing from the University of Leicester, UK.
Shaping a sustainable health system that brings better outcomes for more patients is what drives him forward.
This year Roche’s plans and vision include ensuring sustainable access to innovative medicines and services for bulgarian patients.
“The focus for us remains personalized healthcare, which allows the provision of care tailored to the individual patient and thus contributes to more effective diagnosis and treatment of patients. Accelerating the process of digitalization of the health system, building the appropriate infrastructure and partnership with all relevant stakeholders, all this is also part of our priorities for this year,” said Mr. Sabry.